Effectiveness and Adverse Effects of Deep Brain Stimulation: Umbrella Review of Meta-Analyses

Journal of Neurological Surgery, Part A: Central European Neurosurgery

Volumn 78, Issue 2, 2017, Pages 180-190

  Papageorgiou, Panagiotis N ^a   Deschner, James ^b   Papageorgiou, Spyridon N ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

deep brain stimulation; epilepsy; meta analysis; obsessive compulsive disorder; Parkinson disease; systematic review

Indexed keywords

ADVERSE OUTCOME; BRAIN DEPTH STIMULATION; COCHRANE LIBRARY; DATA BASE; DATA EXTRACTION; DEPRESSION; EPILEPSY; GLOBUS PALLIDUS; HUMAN; INFORMATION RETRIEVAL; MEDLINE; META ANALYSIS; MORTALITY; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; REVIEW; SCOPUS; SUBTHALAMIC NUCLEUS; SYSTEMATIC REVIEW; THERAPY EFFECT; YALE BROWN OBSESSIVE COMPULSIVE SCALE; ADVERSE EFFECTS; OBSESSIVE-COMPULSIVE DISORDER; PROCEDURES; TREATMENT OUTCOME;

DEEP BRAIN STIMULATION; EPILEPSY; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PARKINSON DISEASE; TREATMENT OUTCOME;

EID: 84988433398     PISSN: 21936315     EISSN: 21936323     Source Type: Journal    
DOI: 10.1055/s-0036-1592158     Document Type: Review

References (56)

1. Limousin P., Krack P., Pollak P., et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med: 1998; 339 16 1105 1111
2. Kleiner-Fisman G., Herzog J., Fisman D. N., et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord: 2006; 21 14 S290 S304
3. Perlmutter J. S., Mink J. W. Deep brain stimulation. Annu Rev Neurosci: 2006; 29 229 257
4. Plaha P., Patel N. K., Gill S. S. Stimulation of the subthalamic region for essential tremor. J Neurosurg: 2004; 101 1 48 54
5. Bittar R. G., Kar-Purkayastha I., Owen S. L., et al. Deep brain stimulation for pain relief: a meta-analysis. J Clin Neurosci: 2005; 12 5 515 519
6. Visser-Vandewalle V., Temel Y., Boon P., et al. Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome. Report of three cases. J Neurosurg: 2003; 99 6 1094 1100
7. Greenberg B. D., Gabriels L. A., Malone D. A. Jr., et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry: 2010; 15 1 64 79
8. Lozano A. M., Mayberg H. S., Giacobbe P., Hamani C., Craddock R. C., Kennedy S. H. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry: 2008; 64 6 461 467
9. Schlaepfer T. E., Bewernick B. H. Deep brain stimulation for major depression. Handb Clin Neurol: 2013; 116 235 243
10. Schlaepfer T. E., Lieb K. Deep brain stimulation for treatment of refractory depression. Lancet: 2005; 366 (9495): 1420 1422
11. Wu H., Van Dyck-Lippens P. J., Santegoeds R., et al. Deep-brain stimulation for anorexia nervosa. World Neurosurg: 2013; 80 (3-4): 29.e1 29.e10
12. Hanajima R., Ashby P., Lozano A. M., Lang A. E., Chen R. Single pulse stimulation of the human subthalamic nucleus facilitates the motor cortex at short intervals. J Neurophysiol: 2004; 92 3 1937 1943
13. Uc E. Y., Follett K. A. Deep brain stimulation in movement disorders. Semin Neurol: 2007; 27 2 170 182
14. Guyatt G. H., Oxman A. D., Schünemann H. J., Tugwell P., Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol: 2011; 64 4 380 382
15. Shea B. J., Grimshaw J. M., Wells G. A., et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol: 2007; 7 10
16. Whiting P., Savović J., Higgins J. P., et al. ROBIS: A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol: 2016; 69 225 234
17. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials: 1986; 7 3 177 188
18. Riley R. D., Higgins J. P., Deeks J. J. Interpretation of random effects meta-analyses. BMJ: 2011; 342 d549
19. Higgins J. P., Thompson S. G. Quantifying heterogeneity in a meta-analysis. Stat Med: 2002; 21 11 1539 1558
20. Orsini N., Bottai M., Higgins J., et al. Heterogi: Stata module to quantify heterogeneity in a meta-analysis. Statistical Software Components 2006. Available at: http://www.EconPapers.repec.org/RePEc:boc:bocode:s449201. Accessed March 15, 2015
21. Papageorgiou S. N., Xavier G. M., Cobourne M. T. Basic study design influences the results of orthodontic clinical investigations. J Clin Epidemiol: 2015; 68 12 1512 1522
22. Thompson S. G., Sharp S. J. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med: 1999; 18 20 2693 2708
23. Knapp G., Hartung J. Improved tests for a random effects meta-regression with a single covariate. Stat Med: 2003; 22 17 2693 2710
24. Higgins J. P., Thompson S. G. Controlling the risk of spurious findings from meta-regression. Stat Med: 2004; 23 11 1663 1682
25. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. New York, NY Academic Press: 1988
26. Sterne J. A., Sutton A. J., Ioannidis J. P., et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ: 2011; 343 d4002
27. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ: 1997; 315 (7109): 629 634
28. Harbord R. M., Egger M., Sterne J. A. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med: 2006; 25 20 3443 3457
29. Johnson V. E. Revised standards for statistical evidence. Proc Natl Acad Sci U S A: 2013; 110 48 19313 19317
30. Theodoratou E., Tzoulaki I., Zgaga L., Ioannidis J. P. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ: 2014; 348 g2035
31. Arnaout M., Negida A., El Ashal G., et al. Meta-analysis comparing subthalamic and pallidal deep brain stimulation for patients with Parkinson's disease. Paper presented at: Association of Surgeons in Training International Conference; February 27-March 1, 2015; Glasgow, UK
32. Chambers A., Bowen J. M. Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis. Ont Health Technol Assess Ser: 2013; 13 18 1 37
33. Kisely S., Hall K., Siskind D., Frater J., Olson S., Crompton D. Deep brain stimulation for obsessive-compulsive disorder: a systematic review and meta-analysis. Psychol Med: 2014; 44 16 3533 3542
34. Liu Y., Li W., Tan C., et al. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease. J Neurosurg: 2014; 121 3 709 718
35. Negida A., Arnaout M., El Ashal G., et al. Meta-analysis of mortality following subthalamic and pallidal deep brain stimulation for patients with Parkinson's disease. Paper presented at: ASiT conference; February 27-March 1, 2015; Glasgow, UK
36. Sako W., Miyazaki Y., Izumi Y., Kaji R. Which target is best for patients with Parkinson's disease? A meta-analysis of pallidal and subthalamic stimulation. J Neurol Neurosurg Psychiatry: 2014; 85 9 982 986
37. Sprengers M., Vonck K., Carrette E., Marson A. G., Boon P. Deep brain and cortical stimulation for epilepsy. Cochrane Database Syst Rev: 2014; 6 6 CD008497
38. Borcherding B. G., Keysor C. S., Rapoport J. L., Elia J., Amass J. Motor/vocal tics and compulsive behaviors on stimulant drugs: is there a common vulnerability? Psychiatry Res: 1990; 33 1 83 94
39. Vulink N. C., Denys D., Fluitman S. B., Meinardi J. C., Westenberg H. G. Quetiapine augments the effect of citalopram in non-refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients. J Clin Psychiatry: 2009; 70 7 1001 1008
40. Figee M., de Koning P., Klaassen S., et al. Deep brain stimulation induces striatal dopamine release in obsessive-compulsive disorder. Biol Psychiatry: 2014; 75 8 647 652
41. Hamani C., Pilitsis J., Rughani A. I., et al. American Society for Stereotactic and Functional Neurosurgery; Congress of Neurological Surgeons; CNS and American Association of Neurological Surgeons. Deep brain stimulation for obsessive-compulsive disorder: systematic review and evidence-based guideline sponsored by the American Society for Stereotactic and Functional Neurosurgery and the Congress of Neurological Surgeons (CNS) and endorsed by the CNS and American Association of Neurological Surgeons. Neurosurgery: 2014; 75 4 327 333; quiz 333
42. Follett K. A., Weaver F. M., Stern M., et al. CSP 468 Study Group. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med: 2010; 362 22 2077 2091
43. Odekerken V. J., van Laar T., Staal M. J., et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurol: 2013; 12 1 37 44
44. Doorn K. J., Lucassen P. J., Boddeke H. W., et al. Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease. Prog Neurobiol: 2012; 98 2 222 238
45. Ferrer I., López-Gonzalez I., Carmona M., Dalfó E., Pujol A., Martínez A. Neurochemistry and the non-motor aspects of PD. Neurobiol Dis: 2012; 46 3 508 526
46. Meissner W. G. When does Parkinson's disease begin? From prodromal disease to motor signs. Rev Neurol (Paris): 2012; 168 11 809 814
47. Papageorgiou S. N. Meta-analysis for orthodontists: Part II-Is all that glitters gold? J Orthod: 2014; 41 4 327 336
48. Papageorgiou S. N. Meta-analysis for orthodontists: Part I-How to choose effect measure and statistical model. J Orthod: 2014; 41 4 317 326
49. Papageorgiou S. N., Tsiranidou E., Antonoglou G. N., Deschner J., Jäger A. Choice of effect measure for meta-analyses of dichotomous outcomes influenced the identified heterogeneity and direction of small-study effects. J Clin Epidemiol: 2015; 68 5 534 541
50. Belbasis L., Bellou V., Evangelou E., Ioannidis J. P., Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol: 2015; 14 3 263 273
51. Tsilidis K. K., Kasimis J. C., Lopez D. S., Ntzani E. E., Ioannidis J. P. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ: 2015; 350 g7607
52. Bergey G. K., Morrell M. J., Mizrahi E. M., et al. Long-term treatment with responsive brain stimulation in adults with refractory partial seizures. Neurology: 2015; 84 8 810 817
53. Volkmann J., Mueller J., Deuschl G., et al. DBS study group for dystonia. Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial. Lancet Neurol: 2014; 13 9 875 884
54. Pedrosa D. J., Auth M., Pauls K. A., et al. Verbal fluency in essential tremor patients: the effects of deep brain stimulation. Brain Stimulat: 2014; 7 3 359 364
55. Olazarán J., González B., López-Álvarez J., et al. Motor effects of REAC in advanced Alzheimer's disease: results from a pilot trial. J Alzheimers Dis: 2013; 36 2 297 302
56. Ramasubbu R., Anderson S., Haffenden A., Chavda S., Kiss Z. H. Double-blind optimization of subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study. J Psychiatry Neurosci: 2013; 38 5 325 332